This resolution expresses the House of Representatives' preference for a trade policy that prioritizes American workers, consumers, independent farmers, small businesses, and the environment over corporate interests. It calls for trade agreements to include binding labor and environmental standards, fair wage guarantees, and strict rules of origin to prevent companies from moving jobs overseas. The measure also supports strengthening domestic manufacturing requirements, maintaining tariffs against unfair trade practices, and ensuring that public procurement favors American-made goods. Additionally, it urges the inclusion of provisions to protect data privacy, regulate artificial intelligence, and ensure affordable access to medicine while preventing monopolies.
This non-binding resolution expresses the House of Representatives' view that the FDA should regulate mifepristone, a medication used for abortion, based on scientific evidence rather than political pressure. It highlights over 25 years of data showing the drug is safe and effective when prescribed via telemedicine or dispensed by mail and pharmacy. The bill advocates for policies that ensure equitable access to this care, particularly for marginalized communities facing barriers due to state-level restrictions. By citing numerous studies and medical organizations, the resolution calls for transparent, science-based decisions to maintain current access methods.
The Scientific Integrity Act requires federal agencies that fund, conduct, or oversee research to create and enforce policies ensuring that scientific work remains free from political influence and misconduct. These policies must explicitly prohibit actions such as suppressing data, altering findings, or retaliating against individuals who share research results, while also guaranteeing employees the right to publish their work and participate in professional organizations. To oversee these rules, each agency must appoint a career Scientific Integrity Officer, provide regular ethics training to staff, and publicly report on complaints and policy changes. Additionally, the law mandates that personnel decisions and scientific conclusions be based on expertise and established scientific processes rather than ideology, with periodic reviews to ensure compliance.
The Strength in Diversity Act of 2026 creates a competitive grant program for school districts and state agencies to develop and implement plans that increase racial and socioeconomic diversity in public schools. To receive funding, eligible entities must submit detailed applications outlining how they will reduce isolation in schools, engage with communities, and improve academic outcomes for all students. The bill authorizes the use of funds for activities such as redrawing school boundaries, revising student assignment methods, recruiting diverse staff, and creating transportation plans to encourage attendance across different neighborhoods. Grants are awarded based on the quality of the proposed plan and its potential to meaningfully decrease segregation while maintaining high academic standards.
The Moms Matter Act directs the Department of Health and Human Services to create two main grant programs aimed at improving maternal mental health and reducing health disparities among pregnant and postpartum individuals. The first program provides funding to community organizations and healthcare providers to expand services that integrate mental health care into prenatal and postpartum settings, with a specific focus on groups facing higher risks of mortality and morbidity. The second program offers grants to educational institutions to train and recruit a diverse workforce of mental health professionals who specialize in caring for pregnant and postpartum patients. Both initiatives require recipients to submit annual reports on their activities and outcomes, while the legislation authorizes $25 million and $15 million respectively for each program from fiscal years 2027 through 2031.
The Maternal Health Pandemic Response Act allocates $200 million to the Centers for Disease Control and Prevention to improve data collection, surveillance, and research on how public health emergencies affect pregnant and postpartum individuals. This funding supports efforts to gather detailed demographic information on maternal health outcomes, establish regional centers of excellence, and expand surveys to better reach underrepresented communities. The legislation also requires the CDC to make this data publicly available in a disaggregated format while protecting patient privacy, and mandates public education campaigns to ensure accurate information reaches families and healthcare providers. Additionally, the bill creates a diverse task force to develop federal recommendations for respectful maternity care during emergencies, addressing issues such as telehealth access, doula coverage, and the treatment of mental health and substance use disorders. These measures aim to reduce health disparities and improve care quality for pregnant people from racial and ethnic minority groups during public health crises.
This concurrent resolution expresses support for law enforcement officers. It also appreciates the contributions and recognizes the sacrifices of law enforcement officers.
This bill, known as the Preventing Foreign Interference in American Elections Act, tightens existing rules to stop foreign entities from funding U.S. election activities. It explicitly bans foreign donations used for voter registration, ballot collection, voter ID efforts, get-out-the-vote campaigns, communications targeting specific political parties, and the administration of elections. The legislation also prohibits anyone from knowingly helping a foreign entity violate these donation bans and expands the definition of a contribution to include indirect payments made through intermediaries. To enforce these rules, the bill requires political committees and independent spenders to certify under penalty of perjury that their activities comply with the new restrictions, while limiting the scope of investigations by the Federal Election Commission. Additionally, the act protects the privacy of donors to tax-exempt organizations by restricting federal agencies from collecting or releasing donor identification information, with specific exceptions for the IRS, the Senate and House leadership, the FEC, and court orders.
This bill requires the Department of Veterans Affairs (VA) to partner with private sector stakeholders to identify high-growth emerging tech industries (like AI and semiconductors) and relevant training programs for veterans. It mandates the VA to prominently include these opportunities in veterans' transition programs and on its website, and to create a 90-day expedited process for approving qualifying education courses. The bill also updates existing VA programs by replacing "high technology" with "high technology or emerging technology" in key sections, ensuring emerging tech fields are explicitly included. The provisions expire on September 30, 2027.
The BEACON Act of 2026 establishes two grant programs to improve treatment for veterans with chronic mild traumatic brain injury (mTBI). It authorizes $30 million over three years for grants to nonprofits, academic institutions, and health providers to develop and test non-drug neurorehabilitation approaches, focusing on mental health outcomes, suicide risk reduction, and long-term recovery. The bill requires grantees to prioritize patient-centered care, conduct clinical studies, and partner with VA facilities, with each grant capped at $5 million annually. A separate $10 million annual program funds independent research on TBI treatments, requiring third-party analysis and annual reports to Congress. The pilot programs expire after three years, with evaluations to determine future expansion.
HR 6444 establishes a VA-DoD task force to improve care for veterans and active-duty service members diagnosed with blast-related injuries like traumatic brain injury (TBI) or PTSD. The task force will coordinate research on specific issues (e.g., sleep therapy, gut health, brain inflammation), develop clinical baselines, and create guidelines for evaluating disability claims related to blast exposure. It must report annually to Congress on research progress and claim evaluation recommendations, and will expire on September 30, 2029. The bill directly affects veterans and service members with blast exposure symptoms by focusing research and care coordination on their specific health needs.
This bill (HR 5999) requires the Department of Veterans Affairs (VA) to provide opioid antagonists (like naloxone) to enrolled veterans without needing a prescription or charging a copayment. It directly affects veterans receiving VA healthcare who may need emergency reversal of opioid overdoses. The key provisions mandate the VA to furnish these life-saving medications directly and eliminate both the prescription requirement and cost barrier. This policy change aims to improve immediate access to overdose reversal for veterans without requiring additional medical steps or financial burden.
